Items where Author or Contributor is "Choi, Edward M"
Up a level |
Jump to: Article
Number of items: 5.
Article
Choi, Edward M;
(2021)
COVID-19 vaccines for low- and middle-income countries.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 115 (5).
pp. 447-456.
ISSN 0035-9203
DOI: https://doi.org/10.1093/trstmh/trab045
Choi, Edward M;
Chu, Daniel KW;
Cheng, Peter KC;
Tsang, Dominic NC;
Peiris, Malik;
Bausch, Daniel G;
Poon, Leo LM;
Watson-Jones, Deborah;
(2020)
In-Flight Transmission of SARS-CoV-2.
Emerging infectious diseases, 26 (11).
pp. 2713-2716.
ISSN 1080-6040
DOI: https://doi.org/10.3201/eid2611.203254
Choi, Edward Man-Lik;
Lacarra, Boris;
Afolabi, Muhammed O;
Ale, Boni Maxime;
Baiden, Frank;
Bétard, Christine;
Foster, Julie;
Hamzé, Benjamin;
Schwimmer, Christine;
Manno, Daniela;
+30 more...
D'Ortenzio, Eric;
Ishola, David;
Keita, Cheick Mohamed;
Keshinro, Babajide;
Njie, Yusupha;
van Dijck, Wim;
Gaddah, Auguste;
Anumendem, Dickson;
Lowe, Brett;
Vatrinet, Renaud;
Lawal, Bolarinde Joseph;
Otieno, Godfrey T;
Samai, Mohamed;
Deen, Gibrilla Fadlu;
Swaray, Ibrahim Bob;
Kamara, Abu Bakarr;
Kamara, Michael Morlai;
Diagne, Mame Aminata;
Kowuor, Dickens;
McLean, Chelsea;
Leigh, Bailah;
Beavogui, Abdoul Habib;
Leyssen, Maarten;
Luhn, Kerstin;
Robinson, Cynthia;
Douoguih, Macaya;
Greenwood, Brian;
Thiébaut, Rodolphe;
Watson-Jones, Deborah;
EBOVAC-3/EBL2005 Study Team;
(2023)
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
The Lancet Global health, 11 (11).
e1743-e1752.
ISSN 2214-109X
DOI: https://doi.org/10.1016/S2214-109X(23)00410-2
Manno, Daniela;
Bangura, Agnes;
Baiden, Frank;
Kamara, Abu Bakarr;
Ayieko, Philip;
Kallon, Joseph;
Foster, Julie;
Conteh, Musa;
Connor, Nicholas Edward;
Koroma, Bockarie;
+20 more...
Njie, Yusupha;
Borboh, Paul;
Keshinro, Babajide;
Lawal, Bolarinde Joseph;
Kroma, Mattu Tehtor;
Otieno, Godfrey Tuda;
Deen, Abdul Tejan;
Choi, Edward Man-Lik;
Balami, Ahmed Dahiru;
Gaddah, Auguste;
McLean, Chelsea;
Luhn, Kerstin;
Adetola, Hammed Hassan;
Deen, Gibrilla Fadlu;
Samai, Mohamed;
Lowe, Brett;
Robinson, Cynthia;
Leigh, Bailah;
Greenwood, Brian;
Watson-Jones, Deborah;
(2022)
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.
The Lancet. Infectious diseases, 23 (3).
pp. 352-360.
ISSN 1473-3099
DOI: https://doi.org/10.1016/S1473-3099(22)00594-1
Watson-Jones, Deborah;
Kavunga-Membo, Hugo;
Grais, Rebecca F;
Ahuka, Steve;
Roberts, Natalie;
Edmunds, W John;
Choi, Edward M;
Roberts, Chrissy H;
Edwards, Tansy;
Camacho, Anton;
+9 more...
Lees, Shelley;
Leyssen, Maarten;
Spiessens, Bart;
Luhn, Kerstin;
Douoguih, Macaya;
Hatchett, Richard;
Bausch, Daniel G;
Muyembe, Jean-Jacques;
DRC-EB-001 protocol writing team;
(2022)
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.
BMJ open, 12 (3).
e055596-.
ISSN 2044-6055
DOI: https://doi.org/10.1136/bmjopen-2021-055596